Navigation Links
Brain & Behavior Research Foundation announces spring 2013 conference & free webinars

To raise awareness of the importance of mental health research and scientific advances related to mental illness treatment, prevention and care, the Brain & Behavior Research Foundation presents a mental health conference and free monthly webinars for the public, families and individuals living with mental illness and mental health professionals. The "Discovery to Recovery: A Path to Healthy Minds" conference on Apr. 30, 2013 in Los Angeles and free, monthly "Meet the Scientist" webinars feature leading experts in mental health research. The Brain & Behavior Research Foundation has invested nearly $300 million in NARSAD Grants to more than 3,400 scientists worldwide since 1987, leading to thousands of scientific achievements to improve the lives of those with mental illness.

Foundation spring 2013 conference and webinar schedule and details follow. As new events, speakers and programs are added, they can be viewed at



"Discovery to Recovery: A Path to Healthy Minds"

Date & Time: Tuesday, April 30, 2013, 9:00 a.m :00 p.m. PDT

Registration: $75-100 (includes sessions, materials, breakfast, lunch);, 800-829-8289,

Venue: Luxe Sunset Boulevard Hotel, 11461 Sunset Blvd., Los Angeles, CA 90049,, 310-476-6571

Description: "Discovery to Recovery" features best-selling author Elyn R. Saks, J.D., Ph.D., expert-led panel and sessions on the latest advances in mental illness research, treatments and early intervention to improve the lives of the 1 in 4 people living with a mental illness. Leading figures in mental health will present to the public, families and patients living with a mental illness, caregivers, community leaders, mental health organizations and professionals. Elyn R. Saks, Professor of Law, Psychology and Psychiatry, USC Gould School of Law; author of best-seller "The Center Cannot Hold: My Journey through Madness" (an inspiring account of 30 years of living with schizophrenia). The event moderator is Jeffrey Borenstein, M.D., Brain & Behavior Research Foundation President & CEO; Host, public TV's "Healthy Minds"; and Editor-in-Chief, Psychiatric News.

Sessions and presenters include:

  • Early Psychosis: Risk Factors, Prevention and Recovery, Rachel Loewy, Ph.D., Associate Professor, Psychiatry, University of California, San Francisco

  • Early Diagnosis and Treatment of Schizophrenia, Cameron S. Carter, M.D., Professor, Psychiatry & Psychology, University of California, Davis

  • How Genetic Advances in Autism Spectrum Disorder Inform Development of Therapies, Daniel Geschwind, M.D., Ph.D., Professor, Neurology & Psychiatry, University of California, Los Angeles (UCLA)

  • Risk and Vulnerability for Mood Disorders in Teens, Carrie E. Bearden, Ph.D., Associate Professor, Psychiatry & Biobehavioral Sciences, Semel Institute for Neuroscience and Behavior, UCLA


APRIL 2013

"Meet the Scientist: Bipolar Disorder - Harnessing Brain Plasticity for Improved Overall Outcomes with Dr. Husseini K. Manji"

Date & Time: Tuesday, April 16, 2013, 2:00 p.m :00 p.m. EDT

Registration & Information: For information and to register for free, go to

Presenter: Husseini K. Manji, M.D., is the Global Therapeutic Head of Neuroscience for Johnson and Johnson (J&J) Pharmaceutical Research and Development and Adjunct Professor in Psychiatry and Behavioral Sciences, Duke University School of Medicine. Before joining J&J, Dr. Manji was Chief, Laboratory of Molecular Pathophysiology & Experimental Therapeutics at the National Institute of Mental Health (NIMH), the largest program of its kind in the world. Dr. Manji is a Brain & Behavior Research Foundation Scientific Council Member, NARSAD Independent Investigator Grantee, and 1999 Falcone Prizewinner for Outstanding Achievement in Affective Disorders Research (re-named the Colvin Prize for Outstanding Achievement in Mood Disorders Research in 2012).

Dr. Manji leads a preclinical and clinical global team whose broad goal is to discover and develop new therapeutics for major neurologic, psychiatric and pain-related diseases with a high unmet need for effective treatments. His research has helped to conceptualize severe neuropsychiatric disorders as genetically-influenced disorders of synaptic and neural plasticity, and led to the investigation of key novel therapeutics. The major focus of his research has been the investigation of disease- and treatment-induced changes in gene and protein networks that regulate synaptic and neural plasticity in brain and behavior disorders.

Moderator: Jeffrey Borenstein, M.D., President & CEO, Brain & Behavior Research Foundation; Host, public TV's "Healthy Minds"; Editor-in-Chief, Psychiatric News; and Associate Clinical Professor of Psychiatry, Columbia University College of Physicians & Surgeons.

MAY 2013

"Meet the Scientist Webinar: OCD & Anxiety - Symptoms, Treatment & How to Cope with Dr. Helen Blair Simpson"

Date & Time: Tuesday, May 14, 2:00 p.m :00 p.m. EDT

Registration & Information: For information or to register for free, go to

Presenter: Since 1996, Helen Blair Simpson, M.D., Ph.D., has worked in the New York State Psychiatric Institute's Anxiety Disorders Clinic, first as a NIMH Research Fellow under the mentorship of Dr. Michael Liebowitz and now as an independent researcher and Director of the OCD Research Program. She is a Brain & Behavior Research Foundation 2010 NARSAD Independent Investigator Grantee. Her interdisciplinary work ranges from clinical trials comparing the effects of medication and therapy in OCD to brain imaging studies examining the brain basis of OCD. The goal of her work is to improve the outcome of patients with Obsessive Compulsive Disorder.

Dr. Simpson is a Professor of Clinical Psychiatry, College of Physician and Surgeons at Columbia University and Attending Psychiatrist, Columbia-Presbyterian Medical Center. She holds a BS in Biology from Yale College. Her studies in the M.D.-Ph.D. program at The Rockefeller University/Cornell University Medical College included work on the brain basis of bird song vocalizations as a member of the lab of Dr. Fernando Nottebohm. After completing the M.D.-Ph.D. program, she completed an internship and residency in psychiatry at the Columbia-Presbyterian Medical Center.

Moderator: Jeffrey Borenstein, M.D., President & CEO, Brain & Behavior Research Foundation; Host, public TV's "Healthy Minds"; Editor-in-Chief, Psychiatric News; and Associate Clinical Professor of Psychiatry, Columbia University College of Physicians & Surgeons.


For details about the following upcoming monthly webinars, check

Jun. 11, 2013
"Depression in Children and Adolescents" with Karen Dineen Wagner, M.D., Ph.D., University of Texas Medical Branch at Galveston.

Jul. 9, 2013
Dennis S. Charney, M.D., The Mount Sinai School of Medicine, speaks about resilience - the science of mastering life challenges.

Aug. 13, 2013
Dr. Carlos Zarate, National Institute of Mental Health (NIMH), National Institutes of Health (NIH), discusses ketamine and next generation therapies.

Sept. 9, 2013
Speaker to be announced.

Oct. 8. 2013
Eric J. Nestler, M.D., Ph.D., Mount Sinai School of Medicine, discusses molecular mechanisms of drug addiction.


Contact: Sally Corbett
516-829-0091 x242
Brain & Behavior Research Foundation

Related biology news :

1. Brain & Behavior Research Foundation awards nearly $4 million in new NARSAD grants
2. Obama calls Ben-Gurion U. brain research a great idea
3. Reward linked to image is enough to activate brains visual cortex
4. Atypical brain circuits may cause slower gaze shifting in infants who later develop autism
5. Wireless, implanted sensor broadens range of brain research
6. University of Maryland School of Medicine finds depression stems from miscommunication between brain cells
7. Pig brain models provide insights into human cognitive development
8. Computer model may help athletes and soldiers avoid brain damage and concussions
9. Tickling the brain with magnetic stimulation improves memory in schizophrenia
10. Oxfords Gero Miesenböck is awarded The Brain Prize 2013 for his pioneering work on optogenetics
11. Even mild traumatic brain injuries can kill brain tissue
Post Your Comments:
(Date:11/4/2015)... York , November 4, 2015 ... a new market report published by Transparency Market Research "Home ... Growth, Trends and Forecast 2015 - 2022", the global home ... US$ 30.3 bn by 2022. The market is estimated ... forecast period from 2015 to 2022. Rising security needs ...
(Date:10/29/2015)... Minn. , Oct. 29, 2015   MedNet ... supports the entire spectrum of clinical research, is pleased ... Minnesota High Tech Association (MHTA) as one of only ... in the "Software – Small and Growing" category. The Tekne ... individuals who have shown superior technology innovation and leadership. ...
(Date:10/29/2015)... Va. , Oct. 29, 2015 Daon, ... today that it has released a new version of ... customers in North America have ... IdentityX v4.0 also includes a FIDO UAF certified ... are already preparing to activate FIDO features. These customers ...
Breaking Biology News(10 mins):
(Date:12/1/2015)... Calif. , Dec. 1, 2015 ... Transformational Health program. This program addresses ways companies ... of change. ... Logo - ... aspect of healthcare, as well as the disrupting ...
(Date:12/1/2015)... Dec. 01, 2015 ... of the "2016 Europe Cell Surface ... Technologies, Competitive Strategies, Opportunities for Suppliers--France, Germany, ... offering. --> ) has ... Europe Cell Surface Markers: Country Volume and ...
(Date:12/1/2015)... ... December 01, 2015 , ... RURO, Inc., ... selling system laboratory animal colony management software solution, ezColony®, is now available as ... IT resources., , Many organizations are moving to cloud-hosting ...
(Date:12/1/2015)... 1, 2015 Cepheid (Nasdaq: CPHD ) ... the Piper Jaffray Healthcare Conference in New ... is reaffirming its outlook for the fourth quarter of ... to discussing longer term business model expectations. ...  "We continue to be the fastest growing company of ...
Breaking Biology Technology: